BamSEC and AlphaSense Join Forces
Learn More

CRISPR Therapeutics AG

NASDAQ: CRSP    
Share price (12/20/24): $40.72    
Market cap (12/20/24): $3.476 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4
from S-3ASR 48 pages CRISPR Therapeutics AG Issuer and [Trustee], Trustee Indenture Dated as of [●] Subordinated Debt Securities
12/34/56
EX-4
from S-3ASR 50 pages CRISPR Therapeutics AG Issuer and [Trustee], Trustee Indenture Dated as of [●] Senior Debt Securities
12/34/56
EX-4.1
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Shares
12/34/56
EX-4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Shares
12/34/56
EX-4.1
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Shares
12/34/56
EX-4.2
from S-3ASR 48 pages CRISPR Therapeutics AG Issuer and [Trustee], Trustee Indenture Dated as of [●] Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 49 pages CRISPR Therapeutics AG Issuer and [Trustee], Trustee Indenture Dated as of [●] Senior Debt Securities
12/34/56
EX-4.1
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Shares
12/34/56
EX-4.1
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Shares
12/34/56
EX-4.2
from S-3ASR 48 pages CRISPR Therapeutics AG Issuer and [Trustee], Trustee Indenture Dated as of [●] Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 49 pages CRISPR Therapeutics AG Issuer and [Trustee], Trustee Indenture Dated as of [●] Senior Debt Securities
12/34/56
EX-4.3
from S-3 48 pages CRISPR Therapeutics AG Issuer and [Trustee], Trustee Indenture Dated as of [●] Subordinated Debt Securities
12/34/56
EX-4.2
from S-3 49 pages CRISPR Therapeutics AG Issuer and [Trustee], Trustee Indenture Dated as of [●] Senior Debt Securities
12/34/56
EX-4.1
from S-1 24 pages Subscription Agreement Agreement
12/34/56
EX-4
from DRS/A 24 pages Subscription Agreement Agreement
12/34/56